BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 19561645)

  • 1. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.
    Satyanarayana A; Kaldis P
    Oncogene; 2009 Aug; 28(33):2925-39. PubMed ID: 19561645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
    Risal S; Adhikari D; Liu K
    Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK activation by non-cyclin proteins.
    Nebreda AR
    Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
    Moore GD; Ayabe T; Kopf GS; Schultz RM
    Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells.
    Merrick KA; Larochelle S; Zhang C; Allen JJ; Shokat KM; Fisher RP
    Mol Cell; 2008 Dec; 32(5):662-72. PubMed ID: 19061641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
    Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle kinases.
    Pines J
    Semin Cancer Biol; 1994 Aug; 5(4):305-13. PubMed ID: 7803767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdk1 is sufficient to drive the mammalian cell cycle.
    Santamaría D; Barrière C; Cerqueira A; Hunt S; Tardy C; Newton K; Cáceres JF; Dubus P; Malumbres M; Barbacid M
    Nature; 2007 Aug; 448(7155):811-5. PubMed ID: 17700700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of cyclins and cdks in premature infant baboon model of bronchopulmonary dysplasia.
    Das KC; Ravi D
    Antioxid Redox Signal; 2004 Feb; 6(1):117-27. PubMed ID: 14713343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a new family of cyclin-dependent kinase activators.
    Dinarina A; Perez LH; Davila A; Schwab M; Hunt T; Nebreda AR
    Biochem J; 2005 Mar; 386(Pt 2):349-55. PubMed ID: 15574121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period.
    Kang MJ; Koh GY
    J Mol Cell Cardiol; 1997 Jul; 29(7):1767-77. PubMed ID: 9236132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.